We observed that the percentages of memory CD8+ T cells and CD8+ TRM cells, particularly CD8+ CD103- TRM cells, as well as plasmablasts in the MES T were significantly lower in patients with CRC showing T4 stage disease than those with T2-3 stage disease (Figures 5A, B). The gene discussed is CD8A; the disease is colorectal carcinoma.